Depression and anxiety following acute myocardial infarction in women

Liblik, Kiera; Mulvagh, Sharon L.; Hindmarch, Charles; Alavi, Nazanin; Johri, Amer M.

doi:10.1016/j.tcm.2021.07.005

Cited by 29 publications

(17 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Соматогенные депрессии непосредственно связаны с сосудистыми и нейробиологическими нарушениями ЦНС и возникают на фоне осложнений ИБС (последние стадии хронической сердечной недостаточности, желудочковые аритмии, острый коронарный синдром, осложнения при проведении кардиохирургических вмешательств) [17,60]. Наряду с гипотимией в клинической картине соматогенных депрессий доминирует астеноапатическая и дисфорическая симптоматика, также могут быть значительно выражены нарушения когнитивных функций (память, внимание, способность усваивать новую информацию) [61].…”

Section: психопатологическая структура депрессий при ибсunclassified

“…Масштабное кросс-культуральное исследование, включавшее 6222 наблюдения с типом личности D и ИБС, выявило ассоциацию личностного типа D («distressed») с более высокой распространенностью депрессии при ИБС (наряду с повышенным артериальным давлением, курением и недостатком физической активности) [62]. В аналогичном исследовании, проведенном на выборке, включавшей 570 пациентов с ИБС, также отмечено значимое преобладание депрессивных расстройств (дистимии) у лиц с личностным типом D [60]. В свою очередь, депрессия в сочетании с типом личности D демонстрирует неблагоприятное влияние на течение ИБС и ухудшение прогноза заболевания, в том числе за счет ослабления или отказа от ухода за собой и выполнения врачебных предписаний [64,65].…”

Section: личностный преморбид как фактор риска формирования депрессии...unclassified

See 1 more Smart Citation

Clinical and Genetic Aspects of Depression Comorbid Coronary Heart Disease

et al. 2023

View full text Add to dashboard Cite

Objective: to analyze available scientific publications on the problem of clinical and genetic aspects of depressive disorders in patients with coronary heart disease (CHD). Material and methods: by keywords “coronary heart disease”, “mental disorders”, “depression”, “genetics”, “genetic markers”, “polymorphism”, “personality” articles in English and Russian were searched in the MEDLINE/PubMed, Scopus, Web of science, eLibrary databases in the period from 2020 to 2021. Conclusion: depression comorbid CHD is considered as a clinical problem due to its high prevalence, as well as its influence on the features of the course and prognosis of CHD, as well as on the compliance of patients. Heterogeneity of the clinical structure of depressive disorders in CHD (nosogenic, endogenomorphic, endogenous, somatogenic depression) causes difficulties in differential diagnosis and complex therapeutic measures. There are several factors contributing to the onset of depression in CHD patients: biological, clinical, personal characteristics. Genetic markers of depression in CHD, which have prognostic value, require further clarification.

show abstract

Section: психопатологическая структура депрессий при ибсunclassified

Section: личностный преморбид как фактор риска формирования депрессии...unclassified

Clinical and Genetic Aspects of Depression Comorbid Coronary Heart Disease

et al. 2023

View full text Add to dashboard Cite

show abstract

“…8 Women also have depression, 9 anxiety 9 10 and lower health-related quality of life (HRQoL) 11 1 year after an MI and for many women, fear and anxiety about the future and difficulty moving forward in recovery extends beyond 5 years of having an MI. [12][13][14] Stroke is the second most common cause of CVD mortality in women worldwide. 15 Getahun et al 16 also demonstrated an increased risk of stroke in transgender women.…”

Section: Open Accessmentioning

confidence: 99%

“…Moreover, most women are unaware of risk factors or symptoms 8. Women also have depression,9 anxiety9 10 and lower health-related quality of life (HRQoL)11 1 year after an MI and for many women, fear and anxiety about the future and difficulty moving forward in recovery extends beyond 5 years of having an MI 12–14. Stroke is the second most common cause of CVD mortality in women worldwide 15.…”

Section: Introductionmentioning

confidence: 99%

Peer-support interventions for women with cardiovascular disease: protocol for synthesising the literature using an evidence map

et al. 2022

Self Cite

View full text Add to dashboard Cite

IntroductionThe leading cause of death for women is cardiovascular disease (CVD), including ischaemic heart disease, stroke and heart failure. Previous literature suggests peer support interventions improve self-reported recovery, hope and empowerment in other patient populations, but the evidence for peer support interventions in women with CVD is unknown. The aim of this study is to describe peer support interventions for women with CVD using an evidence map. Specific objectives are to: (1) provide an overview of peer support interventions used in women with ischaemic heart disease, stroke and heart failure, (2) identify gaps in primary studies where new or better studies are needed and (3) describe knowledge gaps where complete systematic reviews are required.Methods and analysisWe are building on previous experience and expertise in knowledge synthesis using methods described by the Evidence for Policy and Practice Information (EPPI) and the Coordinating Centre at the Institute of Education. Seven databases will be searched from inception: CINAHL, Embase, MEDLINE, APA PsycINFO, the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials, and Scopus. We will also conduct grey literature searches for registered clinical trials, dissertations and theses, and conference abstracts. Inclusion and exclusion criteria will be kept broad, and studies will be included if they discuss a peer support intervention and include women, independent of the research design. No date or language limits will be applied to the searches. Qualitative findings will be summarised narratively, and quantitative analyses will be performed using R.Ethics and disseminationThe University of Toronto’s Research Ethics Board granted approval on 28 April 2022 (Protocol #42608). Bubble plots (ie, weighted scatter plots), geographical heat/choropleth maps and infographics will be used to illustrate peer support intervention elements by category of CVD. Knowledge dissemination will include publication, presentation/public forums and social media.

show abstract

“…There is growing recognition of the impact of psychosocial factors such as depression and anxiety on cardiovascular disease, as exemplified in recent guidelines from the European Society of Cardiology [1] and a Scientific Statement from the American Heart Association [2]. There is also growing evidence from studies [3][4][5][6] and reviews [7,8] that following an acute coronary syndrome (ACS) women have significantly higher rates of depression and anxiety, which is associated with adverse outcomes such as increased morbidity, rehospitalization, mortality and decreased quality of life. For example, in the EUROASPIRE IV survey of 7,589 patients from 24 countries with coronary heart disease, symptoms of depression were seen in 31% of women and 20% of men, and symptoms of anxiety in 39% of women and 22% of men [4].…”

Section: Doi: 101159/000528624mentioning

confidence: 99%